PDGFRA and glioblastoma: Clinical trials evaluating the efficacy of anti-PDGFRA drugs in patients with glioblastomas are ongoing (Reardon et al, 2005; Wen et al, 2006; Desjardins et al, 2007; Newton, 2007; Raymond et al, 2008).